Simulations Plus Inc
NASDAQ:SLP

Watchlist Manager
Simulations Plus Inc Logo
Simulations Plus Inc
NASDAQ:SLP
Watchlist
Price: 28.33 USD -0.87% Market Closed
Market Cap: 568.6m USD
Have any thoughts about
Simulations Plus Inc?
Write Note

Operating Margin
Simulations Plus Inc

8.8%
Current
20%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
8.8%
=
Operating Profit
6.1m
/
Revenue
70m

Operating Margin Across Competitors

Country US
Market Cap 568m USD
Operating Margin
9%
Country US
Market Cap 36.5B USD
Operating Margin
24%
Country US
Market Cap 31.3B USD
Operating Margin
13%
Country AU
Market Cap 26.4B AUD
Operating Margin
71%
Country US
Market Cap 10.7B USD
Operating Margin
39%
Country US
Market Cap 6.3B USD
Operating Margin
12%
Country JP
Market Cap 934B JPY
Operating Margin
23%
Country US
Market Cap 5.6B USD
Operating Margin
2%
Country SE
Market Cap 53.5B SEK
Operating Margin
-41%
Country US
Market Cap 2.4B EUR
Operating Margin
0%
Country CN
Market Cap 16.2B CNY
Operating Margin
16%
No Stocks Found

Simulations Plus Inc
Glance View

Market Cap
568m USD
Industry
Health Care

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 135 full-time employees. The company provides prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology. The company also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions in support of product approval. The company offers 11 software products for pharmaceutical research and development, which includes GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ADMET Predictor, MedChem Designer, MedChem Studio, PKPlus, KIWI and Monolix Suite of products through Lixoft. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and to academic and regulatory agencies worldwide for use in the conduct of industry-based research. Cognigen Corporation, DILIsym Services, Inc. and Lixoft are its subsidiaries.

SLP Intrinsic Value
19.62 USD
Overvaluation 31%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
8.8%
=
Operating Profit
6.1m
/
Revenue
70m
What is the Operating Margin of Simulations Plus Inc?

Based on Simulations Plus Inc's most recent financial statements, the company has Operating Margin of 8.8%.